Cargando…

Adding glimepiride to current insulin therapy increases high-molecular weight adiponectin levels to improve glycemic control in poorly controlled type 2 diabetes

BACKGROUND: To observe the efficacy and safety of adding glimepiride to established insulin therapy in poorly controlled type 2 diabetes (T2D) and to assess the relationship of changes in the serum high-molecular weight (HMW) adiponectin levels and glycemic control after glimepiride treatment. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Chun-Jun, Zhang, Jing-Yun, Yu, De-Min, Zhang, Qiu-Mei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994470/ https://www.ncbi.nlm.nih.gov/pubmed/24650537 http://dx.doi.org/10.1186/1758-5996-6-41

Ejemplares similares

Dapagliflozin Added to Glimepiride in Patients with Type 2 Diabetes Mellitus Sustains Glycemic Control and Weight Loss Over 48 Weeks: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial
por: Strojek, Krzysztof, et al.
Publicado: (2014)

Comparison of the efficacy of sitagliptin and glimepiride dose‐up in Japanese patients with type 2 diabetes poorly controlled by sitagliptin and glimepiride in combination
por: Shimoda, Seiya, et al.
Publicado: (2013)

Possible effects of glimepiride beyond glycemic control in patients with type 2 diabetes: a preliminary report
por: Nakamura, Ikuko, et al.
Publicado: (2014)

Challenges for Effective Glycemic control in T2DM during Covid-19 pandemic and Use of Glimepiride/Metformin FDC: Opinion from Indian Clinicians
por: Gandhi, Alka, et al.
Publicado: (2022)

Glycemic Control and Awareness of Insulin Therapy
por: Pashchenko, Yegor, et al.
Publicado: (2021)

Baseline Factors Associated With Glycemic Control and Weight Loss When Exenatide Twice Daily Is Added to Optimized Insulin Glargine in Patients With Type 2 Diabetes
por: Rosenstock, Julio, et al.
Publicado: (2012)

Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity
por: Li, Chun-jun, et al.
Publicado: (2012)

Improved oral bioavailability of poorly water-soluble glimepiride by utilizing microemulsion technique
por: Li, Haiying, et al.
Publicado: (2016)

Predictors of poor glycemic control and level of glycemic control among diabetic patients in west Ethiopia
por: Dedefo, Mohammed Gebre, et al.
Publicado: (2020)

Study of Adiponectin Level in Diabetic Adolescent Girls in Relation to Glycemic Control and Complication of Diabetes
por: Dayem, Soha M. Abd El, et al.
Publicado: (2015)

Clinical Evidence and Practice-Based Guidelines on the Utility of Basal Insulin Combined Oral Therapy (Metformin and Glimepiride) in the Current Era
por: Shrivastava, Abhishek, et al.
Publicado: (2023)

Prevalence of Glycemic Control and Factors Associated With Poor Glycemic Control: A Systematic Review and Meta-analysis
por: Bitew, Zebenay Workneh, et al.
Publicado: (2023)

Effect of Added Carbohydrates on Glycemic and Insulin Responses to Children’s Milk Products
por: Brand-Miller, Jennie, et al.
Publicado: (2013)

Impact of Alcohol on Glycemic Control and Insulin Action
por: Steiner, Jennifer L., et al.
Publicado: (2015)

Effects of Improving Glycemic Control with Insulin on Leptin, Adiponectin, Ghrelin and Neuropeptidey Levels in Patients with Type 2 Diabetes Mellitus: a Pilot Study
por: Katsiki, Niki, et al.
Publicado: (2011)

Comparison of Efficacy of Glimepiride, Alogliptin, and Alogliptin-Pioglitazone as the Initial Periods of Therapy in Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Multicenter, Randomized, Controlled Study
por: Kim, Hae Jin, et al.
Publicado: (2022)

Brain adiponectin signaling controls peripheral insulin response in Drosophila
por: Arquier, Nathalie, et al.
Publicado: (2021)

Stimulation of a glycosyl-phosphatidylinositol-specific phospholipase by insulin and the sulfonylurea, glimepiride, in rat adipocytes depends on increased glucose transport
Publicado: (1994)

Effect of coadministration of omega-3 fatty acids with glimepiride on glycemic control, lipid profile, irisin, and sirtuin-1 in type 2 diabetes mellitus patients: a randomized controlled trial
por: Werida, Rehab H., et al.
Publicado: (2023)

Effect of Adding Insulin Glargine on Glycemic Control in Critically Ill Patients Admitted to Intensive Care Units: A Prospective Randomized Controlled Study
por: Nader, Nader D, et al.
Publicado: (2020)

Formulation design and development of matrix diffusion controlled transdermal drug delivery of glimepiride
por: Akram, Muhammad Rouf, et al.
Publicado: (2018)

Ratio of low molecular weight serum adiponectin to the total adiponectin value is associated with type 2 diabetes through its relation to increasing insulin resistance
por: Iwata, Minoru, et al.
Publicado: (2018)

Evaluation of protective action of fenugreek, insulin and glimepiride and their combination in diabetic Sprague Dawley rats
por: Haritha, C., et al.
Publicado: (2013)

Protein Intake Among Patients with Insulin-Treated Diabetes is Linked to Poor Glycemic Control: Findings of NHANES Data
por: Bawadi, Hiba, et al.
Publicado: (2022)

Hyperthyroidism-Associated Insulin Resistance Is Not Mediated by Adiponectin Levels
por: Chu, Chih-Hsun, et al.
Publicado: (2011)

Nocturnal Glycemic Control with New Insulin Glargine 300 U/mL
por: Yu, Neng Chun
Publicado: (2019)

Achieving glycemic control with intensive insulin therapy in the ICU
por: Vakalos, A, et al.
Publicado: (2008)

Effectiveness of Smartphone App–Based Interactive Management on Glycemic Control in Chinese Patients With Poorly Controlled Diabetes: Randomized Controlled Trial
por: Zhang, Lei, et al.
Publicado: (2019)

Glimepiride monotherapy versus combination of glimepiride and linagliptin therapy in patients with HNF1A-diabetes: a protocol for a randomised, double-blinded, placebo-controlled trial
por: Sidelmann Christensen, Alexander, et al.
Publicado: (2018)

Identifying older diabetic patients at risk of poor glycemic control
por: Incalzi, Raffaele Antonelli, et al.
Publicado: (2002)

Formulation and characterization of orodispersible tablet of glimepiride
por: Kinani, Ahmad AB Yosef, et al.
Publicado: (2022)

Anthocyanins increase serum adiponectin in newly diagnosed diabetes but not in prediabetes: a randomized controlled trial
por: Yang, Liping, et al.
Publicado: (2020)

Can Fetuin-A Be a Marker for Insulin Resistance and Poor Glycemic Control in Children with Type 1 Diabetes Mellitus?
por: Şiraz, Ülkü Gül, et al.
Publicado: (2017)

Pharmacodynamic interaction of fenugreek, insulin and glimepiride on sero-biochemical parameters in diabetic Sprague-Dawley rats
por: Haritha, C., et al.
Publicado: (2015)

Glargine insulin: an alternative to regular insulin for glycemic control in critically ill patients
por: Bhattacharyya, M, et al.
Publicado: (2007)

Weight Change in Diabetes and Glycemic and Blood Pressure Control
por: Feldstein, Adrianne C., et al.
Publicado: (2008)

Short‐ and long‐term effect of sitagliptin after near normalization of glycemic control with insulin in poorly controlled Japanese type 2 diabetic patients
por: Fujisawa, Keiko, et al.
Publicado: (2013)

Bilateral lower limb edema induced by rapid improvement of glycemic control with insulin therapy in a subject with poorly controlled type 2 diabetes
por: Kan, Yuki, et al.
Publicado: (2017)

Efficacy of insulin lispro in improving glycemic control in gestational diabetes
por: Deepaklal, M.C., et al.
Publicado: (2014)

Synthesis and Evaluation of the Insulin–Albumin Conjugate with Prolonged Glycemic Control
por: Rao, Shrilakshmi Sheshagiri, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3103o38evlds8v38jg0qv4vsel